Clare Gilson - Concepedia

Author

Clare Gilson

University College London ORCID

Also Known As

Andrew Worster, C. Gilson, C.E. Gilson, Clare Gilson, Gilson, Clare, Louise Brown, Sharmistha Ghosh

Publications

Citations

H-Index

Concepts

All Affiliations

University College London Institute of Cancer Research University of Glasgow Cardiff University MRC Clinical Trials Unit at UCL

About

Clare Gilson is an author at University College London specializing in urology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	303
2	Pharmacology	2	2	85
3	Cancer Therapeutics	2	2	80
4	Health Sciences	1	1	61
5	Radiation Medicine	1	1	61

Clare Gilson

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy Nicholas D. James, Johann S. de Bono, Melissa Spears, New England Journal of Medicine	2017	1.7K
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial Christopher Parker, Nicholas D. James, Chris Brawley, The Lancet	2018	1.2K
Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol Matthew R. Sydes, Melissa Spears, Malcolm D. Mason, Annals of Oncology	2018	240
Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer Alex Hoyle, Adnan Ali, Nicholas D. James, European Urology UrologyMedicine“ High- ”PharmacotherapyProstatic Disease	2019	199
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial Chris Parker, Nicholas D. James, Chris Brawley, PLoS Medicine	2022	112
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol Gerhardt Attard, Laura Murphy, Noel W. Clarke, The Lancet Oncology	2023	85
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476) Nicholas D. James, Noel W. Clarke, Adrian Cook, International Journal of Cancer	2022	72
Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial Malcolm D. Mason, Noel W. Clarke, Nicholas D. James, Journal of Clinical Oncology Cancer ManagementPharmacotherapyGynecology OncologyMetastatic Prostate CancerRadiation Medicine	2017	61
Genomic Profiles of De Novo High- and Low-Volume Metastatic Prostate Cancer: Results From a 2-Stage Feasibility and Prevalence Study in the STAMPEDE Trial Clare Gilson, Fiona C. Ingleby, Duncan C. Gilbert, JCO Precision Oncology	2020	34
Can Iron Treatments Aggravate Epistaxis in Some Patients With Hereditary Hemorrhagic Telangiectasia? Claire L. Shovlin, Clare Gilson, Mark Busbridge, The Laryngoscope	2016	24

Page 1